Topical zinc oxide for open pilonidal sinus wounds: a randomised, double-blind, placebo-controlled multicentre trial
Completed
- Conditions
- Pilonidal excisional woundSurgeryExcision
- Registration Number
- ISRCTN35311675
- Lead Sponsor
- Bispebjerg Hospital (Denmark)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Patients, 18 years or older, with a first-episode of pilonidal abscess requiring surgery are included after giving their written informed consent.
Exclusion Criteria
Previous pilonidal surgery, hypersensitivity to zinc, dementia, insufficiency in Danish, pregnancy or lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to wound closure in days, defined by complete coverage of the<br>wound with visible epithelium.
- Secondary Outcome Measures
Name Time Method Secondary outcomes were:<br>1. Postoperative antibiotic treatment<br>2. Re-operations<br>3. Pain intensity<br>4. Adverse events<br><br>Tertiary outcomes were:<br>1. Serum-zinc levels<br>2. Sick leave